Brief: Lavipharm Q1 Net Profit Up At EUR 1.1 Million
May 23 (Reuters) - Lavipharm SA LPHr.AT :
* Q1 NET PROFIT EUR 1.1 MILLION VERSUS EUR 0.6 MILLION YEAR
AGO
* Q1 EBITDA EUR 2.9 MILLION VERSUS EUR 2.5 MILLION YEAR AGO
* Q1 TOTAL SALES BEFORE CLAWBACK-REBATES EUR 15.0 MILLION
VERSUS
EUR 13.7 MILLION YEAR AGO
* LAVIPHARM SAYS Q1 SALES DO NOT INCLUDE THE PHARMACEUTICAL
PRODUCTS LONARID N AND LONALGAL AS LAVIPHARM BEGAN SALES IN MAY
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY